Lipoprotein Nanoplatform for Targeted Delivery of Diagnostic and Therapeutic Agents
Low-density lipoprotein (LDL) provides a highly versatile natural nanoplatform for delivery of optical and MRI contrast agents, photodynamic therapy agents and chemotherapeutic agents to normal and neoplastic cells that over express LDL receptors (LDLR). Extension to other lipoproteins ranging in diameter from ~5-10 nm (high density lipoprotein, HDL) to over a micron (chilomicrons) is feasible. Loading of contrast or therapeutic agents has been achieved by covalent attachment to protein side chains, intercalation into the phospholipid monolayer and extraction and reconstitution of the triglyceride/cholesterol ester core. Covalent attachment of folate to the lysine side chain amino groups was used to reroute the LDL from its natural receptor (LDLR) to folate receptors and could be utilized to target other receptors. A semi-synthetic nanoparticle has been constructed by coating magnetite iron oxide nanoparticles (MIONs) with carboxylated cholesterol and overlaying a monolayer of phospholipid to which Apo A1, Apo E or synthetic amphoteric 〈-helical polypeptides were adsorbed for targeting HDL, LDL or folate receptors, respectively. These particles can be utilized for in situloading of magnetite into cells for MRI monitored cell tracking or gene therapy.
KeywordsHepG2 Hepatoma Cationic Amino Acid Cholesteryl Oleate Lysine Side Chain Phospholipid Monolayer
Unable to display preview. Download preview PDF.
- 1.D. E. Vance and J. E. Vance. Biochemistry of Lipids, Lipoproteins and Membranes (Elsevier Science, Amsterdam, 2002).Google Scholar
- 2.J. M. Shaw. Lipoproteins as Carriers of Pharmacological Agents (Marcel Dekker, New York, 1991).Google Scholar
- 3.G. Zheng, J. Chen, H. Li and J. D. Glickson. Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents. Proceedings of the National Academy of Sciences of the United States of America 102, 17757-17762 (2005).PubMedCrossRefGoogle Scholar
- 9.P. C. N. Rensen, R. M. Schiffelers, J. Versluis, M. K. Bijsterbosch, M. E. M. J. van Kuijk-Meuwissen and T. J. C. van Berkel. Human recombinant apolipoprotein E-enriched liposomes can mimic low-density lipoproteins as carriers for the site-specific delivery of antitumor agents. Molec. Pharmacol. 52, 445-455 (1997).Google Scholar
- 12.J. Pietzsch, R. Bergmann, K. Rode, C. Hultsch, B. Pawelke, F. Wuest and J. van den Hoff. Fluorine-18 radiolabeling of low-density lipoproteins: a potential approach for characterization and differentiation of metabolism of native and oxidized low-density lipoproteins in vivo. Nuclear Medicine and Biology 31, 1043-1050 (2004).PubMedCrossRefGoogle Scholar
- 14.M. Krieger, M. S. Brown, J. R. Faust and J. L. Goldstein. Replacement of endogenous cholesteryl esters of low density lipoprotein with exogenous cholesteryl linoleate. Reconstitution of a biologically active lipoprotein particle. Journal of Biological Chemistry 253, 4093-101 (1978).PubMedGoogle Scholar
- 15.M. Krieger, Y. K. Ho and J. R. Falck. Reconstitution of LDL with lipophilic fluorescein derivatives: Quantitative analysis of the receptor activity of human lymphocytes. J. Receptor Res. 3, 361-75 (1983).Google Scholar
- 16.G. Zheng, H. Li, K. Yang, D. Blessington, K. Licha, S. Lund-Katz, B. Chance and J. D. Glickson. Tricarbocyanine cholesteryl laurates labeled LDL: New near infrared fluorescent probes (NIRFs) for monitoring tumors and gene therapy of Familial hypercholesterolemia. Bioorganic & Medicinal Chemistry Letters 12, 1485-1488 (2002).CrossRefGoogle Scholar
- 17.S. P. Wu, I. Lee, P. P. Ghoroghchian, P. R. Frail, G. Zheng, J. D. Glickson and M. J. Therien. Nearinfrared optical Imaging of B16 melanoma cells via low-density lipoprotein-mediated uptake and delivery of high emission dipole strength tris[(porphinato)zinc(II)] fluorophores. Bioconjugate Chemistry 16, 542- 550 (2005).PubMedCrossRefGoogle Scholar
- 18.B. Quistorff, J. C. Haselgrove and B. Chance. High resolution readout of 3-D metabolic organ structure: An automated, low-temperature redox ratio-scanning instrument. Anal. Biochem. 148, 389-400 (1985).Google Scholar
- 21.J. W. M. Bulte, A. S. Arbab, T. Douglas and J. A. Frank. in Imaging in Biological Research, Pt B 275-299 (2004).Google Scholar
- 22.K. A. Hinds, J. M. Hill, E. M. Shapiro, M. O. Laukkanen, A. C. Silva, C. A. Combs, T. R. Varney, R. S. Balaban, A. P. Koretsky and C. E. Dunbar. Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood 102, 867-872 (2003).PubMedCrossRefGoogle Scholar